SOPHiA GENETICS (SOPH) Operating Income (2020 - 2025)
Historic Operating Income for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$17.9 million.
- SOPHiA GENETICS's Operating Income fell 1626.64% to -$17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$69.8 million, marking a year-over-year decrease of 259.14%. This contributed to the annual value of -$66.6 million for FY2024, which is 1103.63% up from last year.
- SOPHiA GENETICS's Operating Income amounted to -$17.9 million in Q3 2025, which was down 1626.64% from -$18.5 million recorded in Q2 2025.
- SOPHiA GENETICS's 5-year Operating Income high stood at -$14.1 million for Q1 2021, and its period low was -$25.0 million during Q1 2022.
- Its 5-year average for Operating Income is -$18.6 million, with a median of -$18.5 million in 2025.
- The largest annual percentage gain for SOPHiA GENETICS's Operating Income in the last 5 years was 9977.38% (2021), contrasted with its biggest fall of 21728946.03% (2021).
- SOPHiA GENETICS's Operating Income (Quarter) stood at -$21.0 million in 2021, then rose by 28.21% to -$15.1 million in 2022, then decreased by 25.61% to -$18.9 million in 2023, then grew by 7.93% to -$17.4 million in 2024, then decreased by 2.4% to -$17.9 million in 2025.
- Its last three reported values are -$17.9 million in Q3 2025, -$18.5 million for Q2 2025, and -$16.0 million during Q1 2025.